Construction and characterization of recombinant MTBVAC. HIV, a new live attenuated vaccine against HIV and tuberculosis

Construction and characterization of recombinant MTBVAC. HIV, a new live attenuated vaccine against HIV and tuberculosis

Bibliographic Details
Main Authors:	Saubi, N, Broset, E, Guitart, N, Aguilo, N, Uranga, S, Kilpelainen, A, Eto, Y, Hanke, T, Gonzalo-Asensio, J, Martin, C, Joseph, J
Format:	Conference item
Published:	Mary Ann Liebert 2018

Similar Items

MTBVAC-based TB-HIV vaccine is safe, elicits HIV-T cell responses, and protects against Mycobacterium tuberculosis in Mice
by: Broset, E, et al.
Published: (2019)

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
by: Esther Broset, et al.
Published: (2019-06-01)

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
by: Jesus Gonzalo-Asensio, et al.
Published: (2017-12-01)

MTBVAC from discovery to clinical trials in tuberculosis-endemic countries
by: Dessislava Marinova, et al.
Published: (2017-06-01)

Priming with recombinant BCG expressing novel HIV-1 conserved mosaic immunogens and boosting with recombinant ChAdOx1 is safe, stable, and elicits HIV-1-specific T-cell responses in BALB/c mice
by: Hanke, T, et al.
Published: (2019)

Recombinant BCG expressing HTI prime and recombinant ChAdOx1 boost is safe and elicits HIV-1-specific T-cell responses in BALB/c mice
by: Kilpeläinen, A, et al.
Published: (2019)

Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
by: Athina Kilpeläinen, et al.
Published: (2019-08-01)

Preclinical development of BCG.HIVA(2auxo.int), harboring an integrative expression vector, for a HIV-TB pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
by: Mahant, A, et al.
Published: (2017)

Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
by: Aakash Mahant, et al.
Published: (2017-08-01)

Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned
by: Athina Kilpeläinen, et al.
Published: (2018-11-01)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
by: Narcís Saubi, et al.
Published: (2020-11-01)

EXPERIENCE OF USING TUBERCULOUS RECOMBINANT ALLERGEN FOR DIAGNOSTICS OF TUBERCULOSIS IN HIV PATIENTS
by: N. V. Eysmont
Published: (2015-10-01)

Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice
by: Chun-Wei Chen, et al.
Published: (2022-12-01)

Vaccine Platform for Prevention of Mother-to-Child Transmission of HIV-1 through Breastfeeding
by: Im, E, et al.
Published: (2008)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024-12-01)

“It is not easy”: Experiences of people living with HIV and tuberculosis on Tuberculosis treatment in Uganda
by: Ruth Nabisere-Arinaitwe, et al.
Published: (2023-12-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
by: Alvarez, MPP, et al.
Published: (2024)

Engineering New E.coli-Mycobacterial Shuttle Vector for a Dual HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
by: Saubi, N, et al.
Published: (2013)

Expression of Chimeric HPV-HIV Protein L1P18 in <i>Pichia pastoris</i>; Purification and Characterization of the Virus-like Particles
by: Yoshiki Eto, et al.
Published: (2021-11-01)

Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine
by: Saubi, N, et al.
Published: (2012)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
by: Hopkins, R, et al.
Published: (2011)

Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG
by: Saubi, N, et al.
Published: (2012)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
by: Andrew D. White, et al.
Published: (2021-01-01)

HIV INFECTION AND TUBERCULOSIS IN RUSSIA
by: V. V. Pokrovsky, et al.
Published: (2014-06-01)

Newborn mice vaccination with BCG.HIVA²²² + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes.
by: Saubi, N, et al.
Published: (2011)

Screening people living with HIV before tuberculosis preventative therapy.
by: Godfrey-Faussett, P, et al.
Published: (1999)

Newborn Mice Vaccination with BCG.HIVA(222) plus MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
by: Saubi, N, et al.
Published: (2011)

Tuberculosis and HIV coinfection and rifampicin-resistant tuberculosis among patients living with HIV in Northern part of West Bengal, India
by: Tapati Mondal, et al.
Published: (2023-01-01)

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes
by: Hanke T, et al.
Published: (2009-10-01)

Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016–2022
by: Deus Lukoye, et al.
Published: (2023-03-01)

Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan
by: Lisa Kawatsu, et al.
Published: (2022-12-01)

Properties of recombinant HIV and SIV antigens
by: Jowett, J, et al.
Published: (1992)

EXTRAPULMONARY TUBERCULOSIS IN HIV PATIENTS
by: M. V. Sinitsyn, et al.
Published: (2017-12-01)

Recombination following superinfection by HIV-1.
by: Fang, G, et al.
Published: (2004)

Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys
by: Jiang, S, et al.
Published: (2007)

Improving management of tuberculosis in people living with HIV in South Africa through integration of HIV and tuberculosis services: a proof of concept study
by: Irit Sinai, et al.
Published: (2018-09-01)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
by: Ahmed, T, et al.
Published: (2012)

Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans.
by: Elliott, A, et al.
Published: (2003)

Lifestyle of Women Living with HIV (Case Study: Women Living with HIV in the Positive Club of Kerman)
by: E Amiri, et al.
Published: (2022-05-01)

Latent Tuberculosis Infection and Associated Risk Factors among People Living with HIV and HIV-Uninfected Individuals in Lithuania
by: Elzbieta Matulyte, et al.
Published: (2023-07-01)